Allscripts Healthcare Solutions (NASDAQ:MDRX) Raised to “Sell” at BidaskClub
MDRX has been the topic of a number of other reports. TheStreet lowered Allscripts Healthcare Solutions from a c- rating to a d+ rating in a research note on Tuesday, August 13th. Robert W. Baird set a $13.00 price objective on Allscripts Healthcare Solutions and gave the stock a buy rating in a research note on Monday, August 12th. Evercore ISI reiterated a hold rating and issued a $11.50 price objective on shares of Allscripts Healthcare Solutions in a research note on Sunday, August 11th. ValuEngine lowered Allscripts Healthcare Solutions from a hold rating to a sell rating in a research note on Friday, July 26th. Finally, Jefferies Financial Group began coverage on Allscripts Healthcare Solutions in a research note on Friday, August 23rd. They issued a buy rating and a $13.00 price objective on the stock. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company. The company has a consensus rating of Hold and an average price target of $12.36.
NASDAQ MDRX traded up $0.06 during trading on Wednesday, hitting $10.44. 1,385,485 shares of the company traded hands, compared to its average volume of 1,384,526. Allscripts Healthcare Solutions has a 12 month low of $8.54 and a 12 month high of $14.82. The business has a fifty day simple moving average of $9.57 and a 200 day simple moving average of $10.19. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $1.73 billion, a P/E ratio of 18.98, a PEG ratio of 2.03 and a beta of 1.38.
Several institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in shares of Allscripts Healthcare Solutions by 2.2% in the second quarter. Vanguard Group Inc. now owns 16,523,536 shares of the software maker’s stock worth $192,169,000 after purchasing an additional 363,005 shares during the period. Tamarack Advisers LP increased its stake in shares of Allscripts Healthcare Solutions by 10.6% in the second quarter. Tamarack Advisers LP now owns 3,925,000 shares of the software maker’s stock worth $45,726,000 after purchasing an additional 375,000 shares during the period. Neuberger Berman Group LLC increased its stake in shares of Allscripts Healthcare Solutions by 8.3% in the first quarter. Neuberger Berman Group LLC now owns 3,121,749 shares of the software maker’s stock worth $29,786,000 after purchasing an additional 239,288 shares during the period. Northern Trust Corp grew its position in Allscripts Healthcare Solutions by 9.7% during the second quarter. Northern Trust Corp now owns 2,906,636 shares of the software maker’s stock worth $33,804,000 after buying an additional 256,892 shares in the last quarter. Finally, Geode Capital Management LLC grew its position in Allscripts Healthcare Solutions by 7.1% during the fourth quarter. Geode Capital Management LLC now owns 2,513,987 shares of the software maker’s stock worth $24,234,000 after buying an additional 167,430 shares in the last quarter.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.
Recommended Story: Equal Weight Rating
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.